These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
54. Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy. Feldkötter M; Schwarzer V; Wirth R; Wienker TF; Wirth B Am J Hum Genet; 2002 Feb; 70(2):358-68. PubMed ID: 11791208 [TBL] [Abstract][Full Text] [Related]
55. Type 0 Spinal Muscular Atrophy: Further Delineation of Prenatal and Postnatal Features in 16 Patients. Grotto S; Cuisset JM; Marret S; Drunat S; Faure P; Audebert-Bellanger S; Desguerre I; Flurin V; Grebille AG; Guerrot AM; Journel H; Morin G; Plessis G; Renolleau S; Roume J; Simon-Bouy B; Touraine R; Willems M; Frébourg T; Verspyck E; Saugier-Veber P J Neuromuscul Dis; 2016 Nov; 3(4):487-495. PubMed ID: 27911332 [TBL] [Abstract][Full Text] [Related]
56. From Clinical Trials to Clinical Practice: Practical Considerations for Gene Replacement Therapy in SMA Type 1. Al-Zaidy SA; Mendell JR Pediatr Neurol; 2019 Nov; 100():3-11. PubMed ID: 31371124 [TBL] [Abstract][Full Text] [Related]
57. Incidence of infantile spinal muscular atrophy on Shikoku Island of Japan. Okamoto K; Fukuda M; Saito I; Urate R; Maniwa S; Usui D; Motoki T; Jogamoto T; Aibara K; Hosokawa T; Konishi Y; Arakawa R; Mori K; Ishii E; Saito K; Nishio H Brain Dev; 2019 Jan; 41(1):36-42. PubMed ID: 30093179 [TBL] [Abstract][Full Text] [Related]
58. A preliminary report on spinal muscular atrophy lymphoblastoid cell lines: are they an appropriate tool for drug screening? Dayangaç-Erden D; Topaloğlu H; Erdem-Yurter H Adv Ther; 2008 Mar; 25(3):274-9. PubMed ID: 18345520 [TBL] [Abstract][Full Text] [Related]